• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成毒扁豆碱类似物及其抗胆碱酯酶活性评价。

Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.

机构信息

College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China.

出版信息

Bioorg Med Chem Lett. 2010 Mar 1;20(5):1532-4. doi: 10.1016/j.bmcl.2010.01.097. Epub 2010 Jan 25.

DOI:10.1016/j.bmcl.2010.01.097
PMID:20144867
Abstract

A series of physostigmine analogues were prepared and evaluated for cholinesterase inhibition activities, including acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Most of them showed potent inhibition activities against AChE, in which compound 17 especially exhibited significantly higher selectivity over BChE than phenserine, a compound currently on clinical trial. Discussion about the relationships between structure and activity of these derivatives was also presented.

摘要

一系列毒蕈堿类似物被制备并评估了其对乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BChE)的抑制活性。它们大多数对 AChE 具有很强的抑制活性,其中化合物 17 对 BChE 的选择性明显高于正在临床试验中的化合物苯甲曲秦。还讨论了这些衍生物的结构与活性之间的关系。

相似文献

1
Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.合成毒扁豆碱类似物及其抗胆碱酯酶活性评价。
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1532-4. doi: 10.1016/j.bmcl.2010.01.097. Epub 2010 Jan 25.
2
Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.设计、合成和评价氨甲酰基修饰的(-)-N(1)-苯乙基降烟碱衍生物作为选择性丁酰胆碱酯酶抑制剂。
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1721-3. doi: 10.1016/j.bmcl.2010.01.035. Epub 2010 Jan 20.
3
Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.用于阿尔茨海默病的新型基于苯丝氨酸的丁酰胆碱酯酶选择性抑制剂的合成。
J Med Chem. 1999 May 20;42(10):1855-61. doi: 10.1021/jm980459s.
4
Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.(3aS)-N1,N8-双去甲毒扁豆碱、(3aS)-N1,N8-双去甲毒扁豆胺及其对映异构体以及毒扁豆碱其他潜在代谢产物的合成与抗胆碱酯酶活性
J Med Chem. 1998 Jun 18;41(13):2371-9. doi: 10.1021/jm9800494.
5
Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.合成苯并噻嗪类似物及其胆碱酯酶抑制活性的评价。
Bioorg Med Chem. 2012 Aug 15;20(16):4901-14. doi: 10.1016/j.bmc.2012.06.048. Epub 2012 Jul 6.
6
Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.黄酮类衍生物作为强效乙酰胆碱酯酶抑制剂的设计、合成与评价
Bioorg Med Chem. 2009 Sep 15;17(18):6692-8. doi: 10.1016/j.bmc.2009.07.072. Epub 2009 Aug 3.
7
Total syntheses and anticholinesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues.(3aS)-N(8)-去甲毒扁豆碱、(3aS)-N(8)-去甲新斯的明、它们的对映异构体以及其他N(8)-取代类似物的全合成与抗胆碱酯酶活性
J Med Chem. 1997 Aug 29;40(18):2895-901. doi: 10.1021/jm970210v.
8
Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.设计、合成、评价及 N(1)-取代的去甲海因衍生物的定量构效关系分析作为选择性丁酰胆碱酯酶抑制剂。
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1718-20. doi: 10.1016/j.bmcl.2010.01.057. Epub 2010 Jan 20.
9
Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.实验性阿尔茨海默病药物苯丝氨酸的甲基类似物:乙酰胆碱酯酶和丁酰胆碱酯酶抑制作用的合成及构效关系
J Med Chem. 2001 Nov 22;44(24):4062-71. doi: 10.1021/jm010080x.
10
Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors.功能化香豆素作为乙酰胆碱酯酶抑制剂的合成及生物学评价
Eur J Med Chem. 2005 Dec;40(12):1307-15. doi: 10.1016/j.ejmech.2005.07.014. Epub 2005 Sep 21.

引用本文的文献

1
Recent Advances in the Treatment and Management of Alzheimer's Disease: A Precision Medicine Perspective.阿尔茨海默病治疗与管理的最新进展:精准医学视角。
Curr Top Med Chem. 2024;24(19):1699-1737. doi: 10.2174/0115680266299847240328045737.
2
Photobiomodulation in Alzheimer's Disease-A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?阿尔茨海默病中的光生物调节——一种现有药物制剂和纳米医学的补充方法?
Pharmaceutics. 2023 Mar 11;15(3):916. doi: 10.3390/pharmaceutics15030916.
3
Natural Products from Plants and Algae for Treatment of Alzheimer's Disease: A Review.
植物和藻类来源的天然产物治疗阿尔茨海默病的研究进展。
Biomolecules. 2022 May 12;12(5):694. doi: 10.3390/biom12050694.
4
Biocatalytic C3-Indole Methylation-A Useful Tool for the Natural-Product-Inspired Stereoselective Synthesis of Pyrroloindoles.生物催化 C3-吲哚甲基化——一种用于天然产物启发的吡咯并吲哚立体选择性合成的有用工具。
Angew Chem Int Ed Engl. 2021 Oct 18;60(43):23412-23418. doi: 10.1002/anie.202107619. Epub 2021 Sep 17.
5
The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer's Disease.乙酰胆碱酯酶抑制剂治疗阿尔茨海默病的研究现状
J Cent Nerv Syst Dis. 2021 Jul 7;13:11795735211029113. doi: 10.1177/11795735211029113. eCollection 2021.
6
Vitamin B3-Based Biologically Active Compounds as Inhibitors of Human Cholinesterases.基于维生素 B3 的生物活性化合物作为人胆碱酯酶抑制剂。
Int J Mol Sci. 2020 Oct 29;21(21):8088. doi: 10.3390/ijms21218088.
7
Alzheimer's Disease Pharmacotherapy in Relation to Cholinergic System Involvement.阿尔茨海默病药物治疗与胆碱能系统参与的关系。
Biomolecules. 2019 Dec 26;10(1):40. doi: 10.3390/biom10010040.
8
Cholinesterase inhibitors as Alzheimer's therapeutics (Review).胆碱酯酶抑制剂作为阿尔茨海默病的治疗药物(综述)。
Mol Med Rep. 2019 Aug;20(2):1479-1487. doi: 10.3892/mmr.2019.10374. Epub 2019 Jun 11.
9
A new and convenient synthetic way to 2-substituted thieno[2,3-b]indoles.一种合成2-取代噻吩并[2,3-b]吲哚的新颖便捷方法。
Beilstein J Org Chem. 2015 Jun 11;11:1000-7. doi: 10.3762/bjoc.11.112. eCollection 2015.
10
New acetylcholinesterase inhibitors for Alzheimer's disease.用于治疗阿尔茨海默病的新型乙酰胆碱酯酶抑制剂。
Int J Alzheimers Dis. 2012;2012:728983. doi: 10.1155/2012/728983. Epub 2011 Dec 15.